We are happy to share a positive information to all who support Ukraine and our clinical trials industry. Please find below a report from the State Expert Center of the Ministry of Health of Ukraine regarding the state of clinical trials in 2023, published on 29th January 2024.
In 2023, the State Expert Center received 41 statements from sponsors regarding the start of clinical trials in Ukraine. The main therapeutic areas where clinical trials were carried out were oncology, allergology, neurology, cardiology, and dermatology. At the beginning of the year, 400 clinical trials were registered in Ukraine, out of which 309 started. This represents a 64% increase in the number of clinical trials started in 2023. The number of local ethics commissions also increased from 308 in 2022 to 390 in 2023.
The number of clinical trials in Ukraine launched in 2023 increased by 64%!
In 2023, the Expert Center conducted 40 audits (39 sites, 1 CRO office), which is similar to the number of audits conducted in 2022 (45), the year before the russian aggression. Get the full report of the Expert Center for 2023.
MICS Ukraine is operating on a full scale
Medicover Integrated Clinical Services business unit in Ukraine operates across the country in a full scale and supports 62 clinical trials projects. MICS Ukraine is presented by actively functioning 6 labs and 320+ blood-collection offices. Moreover, all global courier companies resumed their logistics support in the country. I hope this information and current data help our partners and decision-makers to find possibilities for returning to Ukraine! – says Oleksii Gaidamak, Business Development Director, Medicover Integrated Clinical Services Ukraine.
Find out more about our Central Laboratory Services.
